EndoQuest Robotics

Positioning

EndoQuest Robotics (Houston, TX; founded 2017) is a pre-commercial medical device company developing the Endoluminal Surgical (ELS) / Flexible Robotic Surgical System for scar-free surgery through natural orifices, targeting GI endoscopic submucosal dissection (ESD). It completed enrollment in its pivotal PARADIGM IDE trial (50 robotic ESD procedures across 49 subjects) in mid-2026 with strong preliminary results and is preparing an FDA De Novo submission; no product is yet cleared or commercially sold. The open question is regulatory clearance timing and commercial ramp against entrenched giants like Intuitive.

Latest signals

• 14 Sept 2026EndoQuest Robotics installed its first endoluminal surgical system at Brigham and Women’s Hospital.EndoQuest Robotics
• 14 Sept 2026EndoQuest Robotics was accepted into the FDA’s Safer Technologies Program.EndoQuest Robotics
• 14 Sept 2026EndoQuest Robotics appointed Dr. Todd Wilson as chief medical officer.EndoQuest Robotics
• 14 Sept 2026EndoQuest Robotics closed $42 million in financing for endoluminal robotics development.EndoQuest Robotics
• 14 Sept 2026EndoQuest Robotics entered a multi-year partnership with Proximie.EndoQuest Robotics

15 signals name EndoQuest Robotics. Members see all of them, filtered by topic, source and date.

Facts, with sources

• 14 Sept 2026<25m (pre-revenue/pre-commercial)Revenue band · EndoQuest Robotics
• 14 Sept 2026Partnership with OMNIVISION to integrate an image sensor into the flexible robotic system.Partnership · EndoQuest Robotics
• 14 Sept 2026First endoluminal surgical system installed at Brigham and Women’s Hospital.Deployment · EndoQuest Robotics
• 14 Sept 2026Partnership with VirtaMed to develop an endoluminal robotic training simulator.Partnership · EndoQuest Robotics

16 facts on file. Members see all of them with the source link.

Scores, Robotics (of 10)

Traction: deployment, production, commercials, progress. Capability: technology, positioning, firepower, leverage.

Categories